Definitive Contract 75N91020C00057

Award Date 9/16/20
Potential Completion Date 9/15/21
Potential Value $400K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Derwood, MD 20855, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is a Phase I Small Business Innovation Research contract valued at approximately $400,000 awarded by the National Institutes of Health National Cancer Institute to Charles River Analytics, Inc. of Cambridge, Massachusetts. The contract is for one year ending in June 2021 to conduct research and development in support of the agency's TOPIC 412: WEARABLE HEALTH INFORMATICS PLATFORM FOR EXTENSIBLE RESEARCH program. Specifically, the contractor will develop a wearable...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,759 Firm Fixed Price contract to Litmus Health, Inc., a small business, to develop an extensible and scalable platform for data integration from wearable sensors to generate novel analytics for cancer patients. This award is associated with the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This $390,181 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Smart Information Flow Technologies LLC for research activities aligned with TOPIC 425: CHARACTERIZING HUMAN ACTIVITIES FOR CANCER HEALTH AWARENESS under the Small Business Innovation Research Program Phase I solicitation. The prime contractor will conduct research and development at its Minneapolis, Minnesota location to deliver innovative solutions in cancer health awareness as...
This SBIR Phase I contract was awarded by the National Institutes of Health National Cancer Institute to Outcomes4Me Inc. for $452,514. The contract is for the period of September 16, 2020 through September 15, 2022 and involves developing mobile health technology to utilize cancer survivorship navigation for patient benefit. The solicitation sought proposals to conduct research and development in support of NIH and CDC agency missions, including topics related to cancer immunotherapy...
This SBIR Phase I contract from the National Cancer Institute, valued at $361,254, was awarded to Avident Health LLC. The firm will develop its MyNavigator mHealth application for use in patient navigator breast cancer care workflows, as requested under NIH Solicitation 406. This total small business set-aside solicitation sought proposals for Phase I and Phase II SBIR contracts to conduct R&D supporting NIH and CDC agency missions, including alternatives to cell culture materials and cancer...
This is a $1,499,973.00 Small Business Innovation Research (SBIR) Phase II contract awarded to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract was awarded by the National Cancer Institute, a civilian federal agency, to develop connected health technologies to address and improve health outcomes for long-term cancer survivors. The contract has a performance period of September 13, 2021 to September 12, 2023, with an ultimate completion date of...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This $454,907 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Sentimetrix, Inc. for research under the SBIR Phase I topic "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)". The contract is associated with the Department of Health and Human Services' National Institutes of Health and Centers for Disease Control and Prevention SBIR solicitation seeking innovative solutions across cancer research, infectious diseases, public...

This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood, Maryland. This total small business set-aside award responds to a broader NIH/CDC SBIR solicitation focused on advancing cancer research through technologies such as artificial intelligence, intra-tumor sensing, and clinical trials tools.

Generated 12/29/23, 3:20 PM